Spyre Therapeutics Completes $316 Million Public Offering

Ropes & Gray has advised Spyre Therapeutics. Covington & Burling LLP has advised the underwriters.Spyre Therapeutics, Inc., a clinical-stage biotechnology company, has concluded a public offering…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here